Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
54 Results Found
Central Vermont Medical Center | Vermont
Central Vermont Medical Center (CVMC) erves a population of 66,000 and employs nearly 1,400 people in one of the most rural regions of the country. The not-for-profit community health care provider treats more than 25,000 patients through its Emergency Department, provides care to over 164,000 Vermonters in its 27 outpatient facilities, and performs over 3,000 outpatient surgeries annually.
340B Advocacy Alliance Bulletin - October 23, 2025
The Senate Committee on Health, Education, Labor and Pensions today held a hearing discussing the 340B Drug Pricing Program and its growth and impacts on patients.
AHA 340B Advocacy Alliance Bulletin - October 17, 2025
Senate HELP Committee to hold hearing on 340B program
AHA Letter to HRSA Re: The 340B Rebate Model Pilot Program
AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.
AHA 340B Advocacy Alliance August 21, 2025
The AHA 340B Advocacy Alliance will host a call Aug. 28 at 12:30 p.m. ET to provide insights into the association’s comments to the Health Resources and Services Administration about the agency’s 340B Rebate Model Pilot Program, which will be shared with members next week.
AHA, Health Associations Comment on HRSA Notice of a 340B Rebate Model Pilot Program
AHA, health associations initial comment on the Health Resources and Services Administration’s (HRSA) notice of a 340B Rebate Model Pilot Program.
TAKE ACTION: Urge Lawmakers to Reject Medicaid Cuts, Protect Access to Care
With your senators and representatives home in their states and districts for the next two weeks, please reach out to your lawmakers and urge them to reject funding cuts to Medicaid and other health care programs as part of reconciliation bill.
AHA Letter to FTC and DOJ Re: Anticompetitive Activity by Drug Companies with Respect to 340B “Rebate Models”
AHA letter to the Federal Trade Commission and Department of Justice regarding anticompetitive activity by drug companies with respect to 340B “rebate models.”